CRL opens European Central Lab

1. NEWS RELEASE
Global clinical testing specialist to build European laboratory
hub in UK
24 August 2009: Clinical Reference Laboratory Inc, (Kansas, USA) (“CRL Global Services”), one
of the world’s largest independent clinical testing laboratory operations, has concluded a landmark
deal with Quotient Bioresearch (Cambridgeshire, UK) that will see CRL Global Services establish
its new European laboratory hub in the UK. CRL Global Services has a track record of more than
18 years in delivering testing services to support clinical development programs in the
pharmaceutical, biotechnology and CRO industries. Entering in to this agreement marks a clear
strategic shift – to move away from the company’s earlier partnership within Europe.
CRL Global Services has chosen to construct its own laboratory in Cambridgeshire, UK,
embedded within the existing world-class facilities of Quotient Bioresearch. It will provide a further
full service laboratory arm to CRL Global Services’ existing global structure. The contract also
provides for an immediate close collaboration between the companies on the development and
delivery of new services, particularly in the areas of bioanalysis, biomarkers and microbiology.
Leader of the organisation for more than 10 years, Rajani Prasad, PhD, vice president, clinical
trials and Arnold Verbeek, PhD, general manager of Clinical Reference Laboratory – Europe Ltd,
commented: “Our agreement with Quotient Bioresearch signals a new chapter in CRL’s
development. We are confident that by using our own operations and applying our technology on a
global scale CRL guarantees clients the most streamlined, highest quality and best value available
in clinical trials support.”
David Griffiths, PhD MBA, business development director, Quotient Bioresearch, added: “We are
very pleased to be working together with CRL Global Services as they construct their new
laboratory in the UK. The established capabilities of the two companies are entirely
complementary. I anticipate synergies that will enable us to deliver a joint offering significantly
broader than available from each party working alone.”
CRL Global Services offers leading edge testing services in the areas of clinical trials, corporate
wellness programs, genomics, insurance, and toxicology. The company analyzes over 100 million
tests annually. Importantly, the same core management group has been in place for the past
eighteen years.
Text ends
Notes and contact details follow…
CRL/JOB/003 Page 1 of 2

2. Global clinical testing specialist to build European laboratory hub in UK…/2
About Quotient Bioresearch
Quotient is a leading provider of drug development services with a focus on early-stage drug
development services. The Company offers a unique range of drug development services
through its three principal operating units – Quotient Radiochemistry & Metabolism, Quotient
Bioanalytical Sciences (including Microbiology) and Quotient Clinical. Quotient has grown
rapidly in the past three years, through a combination of both acquisition-led and organic
growth. Quotient Bioresearch is part of Quotient Bioscience Group, which comprises Quotient
Bioresearch, HFL Sport Science and Quotient Biodiagnostics.
For further information: www.quotientbioresearch.com
About Clinical Reference Laboratory
CRL offers leading edge testing services in the areas of Clinical Trials, Corporate Wellness
Programs, Genomics, Insurance, and Toxicology. Analyzing over 100 million tests annually,
CRL is one of the largest privately owned laboratories operating on a national basis. In
addition, it has had the same core management group for the past eighteen years.
For further information: www.crlcorp.com
Media Contacts:
Arnold Verbeek, General Manager of Clinical Reference Laboratory – Europe Ltd
+1 913 488 1021
Richard Kent, Director, Kapler Communications
+44 (0)1480 479 280
CRL/JOB/003 Page 2 of 2